🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2032

Annual patent cliff calendar for 2032 — US pharmaceutical patents by expiration date.

Patents
1,123

Quick answer

1,123 indexed pharmaceutical patents have expiration dates in 2032. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8324181

    Modulation of gene expression by oligomers targeted to chromosomal DNA

    The Board of Regents of the University of Texas System · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8324200

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8324165

    Compositions for treating arthritis comprising HG1023575 polypeptide

    Five Prime Therapeutics, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8323961

    HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8323962

    Molecules with extended half-lives, compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8323679

    Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same

    TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8323706

    Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8323686

    Nanostructures suitable for sequestering cholesterol and other molecules

    Northwestern University · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8323670

    Topical compositions of opioid antagonists and methods for treating skin conditions therewith

    Ak Kimya Ithalat-Ihracat Ve Sanayii A.S. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8323665

    Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin

    The Board of Regents of the University of Texas System · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8323662

    Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein

    IMMUNE DESIGN CORP. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8323671

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8323634

    Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8324155

    Quinoxaline-containing compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8329687

    Pyridooxazepine derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8329181

    Methods for treating B-cell lymphoma by administering an anti-CD20 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8329719

    Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

    Lixte Biotechnology, Inc. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8329662

    Prodrug of an ICE inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8329636

    Carcinoma diagnosis and treatment, based on ODC1 genotype

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8328785

    Use of nanoparticles in the photodynamic treatment of tumors

    The Board of Regents of the University of Texas System · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8329873

    Bispecific single chain Fv antibody molecules and methods of use thereof

    The Regents of the University of California · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8329924

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8329911

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8329900

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8329876

    Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

    Nektar Therapeutics · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8329745

    Small molecule inhibitors of ghrelin O-acyltransferase

    The Board of Regents of the University of Texas System · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8329753

    Combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibition

    The Regents of the University of Colorado · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8329845

    Divided redox-curing type composition

    KURARAY NORITAKE DENTAL INC. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8329744

    Methods of preventing the serotonin syndrome and compositions for use thereof

    Relmada Therapeutics, Inc. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8329702

    Heterocycles useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8329703

    Pyrazole compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8329664

    Anti-viral pyrimidine nucleoside derivatives

    University College Cardiff Consultants Limited · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8329696

    Solid state forms of sitagliptin salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8329691

    Amide compounds and use of the same

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8329182

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8329179

    Death domain containing receptor 4 antibodies and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8329205

    Bioabsorbable composition and coatings of a fatty acid salt, epsilon-caprolactone, a monomer, and homopolymers or copolymers

    Covidien LP · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8329141

    Locoregional internal radionuclide ablation of abnormal tissues

    The Board of Regents of the University of Texas System · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8334260

    sFRP and peptide motifs that interact with sFRP and methods of their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8334273

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8334259

    Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative

    The Board of Regents of the University of Texas System · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8334272

    Methods for nucleic acid transfer into cells

    Northwestern University · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8334294

    4,8-diphenyl-polyazanaphthalene derivatives

    Almirall, S.A. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8334239

    High affinity VEGF-receptor antagonists

    The Board of Regents of the University of Texas System · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8334282

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8334297

    2,4-pyrimidinediamine compounds for treatment of inflammatory disorders

    Rigel Pharmaceuticals, Inc. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8334296

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8334301

    5-Membered heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2032?

1,123 published patents in our USPTO index have expiration dates falling in calendar year 2032.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.